D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CVS holding history
CVS Health Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CVS overviewAll 13F holders of CVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,382,037
- Value
- $143.0M
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,382,037 | $143.0M | 0.1% | −235,485−14.6% | Reduced | Holders |
| Q1 2026 | 1,617,522 | $116.2M | 0.1% | +542,634+50.5% | Added | Holders |
| Q4 2025 | 1,074,888 | $85.3M | 0.1% | −43,255−3.9% | Reduced | Holders |
| Q3 2025 | 1,118,143 | $84.3M | 0.1% | +190,786+20.6% | Added | Holders |
| Q2 2025 | 927,357 | $64.0M | 0.1% | +572,252+161.2% | Added | Holders |
| Q1 2025 | 355,105 | $24.1M | <0.1% | −828,846−70.0% | Reduced | Holders |
| Q4 2024 | 1,183,951 | $53.1M | 0.1% | −2,575,354−68.5% | Reduced | Holders |
| Q3 2024 | 3,759,305 | $236.4M | 0.3% | +2,679,014+248.0% | Added | Holders |
| Q2 2024 | 1,080,291 | $63.8M | 0.1% | +980,372+981.2% | Added | Holders |
| Q1 2024 | 99,919 | $7.97M | <0.1% | −27,822−21.8% | Reduced | Holders |
| Q4 2023 | 127,741 | $10.1M | <0.1% | −744,310−85.4% | Reduced | Holders |
| Q3 2023 | 872,051 | $60.9M | 0.1% | −908,874−51.0% | Reduced | Holders |
| Q2 2023 | 1,780,925 | $123.1M | 0.2% | +309,877+21.1% | Added | Holders |
| Q1 2023 | 1,471,048 | $109.3M | 0.2% | +1,404,822+2,121.3% | Added | Holders |
| Q4 2022 | 66,226 | $6.17M | <0.1% | −121,349−64.7% | Reduced | Holders |
| Q3 2022 | 187,575 | $17.9M | <0.1% | −208,168−52.6% | Reduced | Holders |
| Q2 2022 | 395,743 | $36.7M | 0.1% | +373,779+1,701.8% | Added | Holders |
| Q1 2022 | 21,964 | $2.22M | <0.1% | −39,428−64.2% | Reduced | Holders |
| Q4 2021 | 61,392 | $6.33M | <0.1% | +18,407+42.8% | Added | Holders |
| Q3 2021 | 42,985 | $3.65M | <0.1% | −544,658−92.7% | Reduced | Holders |
| Q2 2021 | 587,643 | $49.0M | 0.1% | −193,436−24.8% | Reduced | Holders |
| Q1 2021 | 781,079 | $58.8M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.